Abstract

Features| August 2022 Safe Injection Practices Richard A. Beers, MD Richard A. Beers, MD Search for other works by this author on: This Site PubMed Google Scholar ASA Monitor August 2022, Vol. 86, 22. https://doi.org/10.1097/01.ASM.0000855664.27093.90 Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn MailTo Cite Icon Cite Get Permissions Search Site Citation Richard A. Beers; Safe Injection Practices. ASA Monitor 2022; 86:22 doi: https://doi.org/10.1097/01.ASM.0000855664.27093.90 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll PublicationsASA Monitor Search Advanced Search Topics: infections, infectious disease prevention / control, needles, risk reduction, syringes, vial, hepatitis c virus, disease outbreaks, portacath, prefilled syringe In October 2022, the ASA House of Delegates approved Recommendations for Safe Injection Practices (asamonitor.pub/3MEhFsB). Safe injection practices are aseptic measures intended to prevent entry and transmission of pathogens during the preparation, administration, and storage of medications or fluids. Safe injection practices reduce the risk of colonizing intravascular catheters or spreading infections among patients from contaminated medication vials. Thompson and colleagues reported 33 outbreaks of patient-to-patient transmission of hepatitis B virus (HBV) and hepatitis C virus (HCV), leading to 448 cases of disease from 1998-2008 (Ann Intern Med 2009;150:33-9). Genome sequencing precisely identified the viral transmission source (BMC Biol 2013;11:76). Anesthesia professionals were involved in eight of these outbreaks, placing 7,000 patients at risk of exposure and 140 documented cases of hepatitis. From 2008-2019, 66 outbreaks (two or more cases) of viral hepatitis associated with health care were reported to the CDC (asamonitor.pub/3mokQts... You do not currently have access to this content.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call